Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25.7K Sell
900
-9,100
-91% -$242K ﹤0.01% 1065
2026
Q2
$241K Buy
+10,000
New +$262K 0.05% 465

Other funds holding PFE

All Options USA's PFE Position: Q3 2026 in Review

All Options USA sold out of Pfizer (PFE) in Q3 2026, closing a stake of 5,167 shares — an estimated $137K sold.

All Options USA first reported a position in PFE in Q2 2026 and held it in 1 quarter. The position peaked at $124K in Q2 2026. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • All Options USA reported no remaining Pfizer position as of Q3 2026 after selling out during the quarter.
  • All Options USA sold 5,167 Pfizer shares in Q3 2026, an estimated $137K.
  • All Options USA first reported a position in Pfizer in Q2 2026 and held it in 1 quarter.
  • All Options USA's Pfizer position peaked at $124K in Q2 2026.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on All Options USA's 13F filing for Q3 2026, filed 12 Nov 2026.